510(k) device
Afinion HbA1c Dx on Afinion 2
Alere Technologies AS · Hemoglobin A1c Test System (PDJ, Class II) · First FDA decision May 7, 2018, newest Nov 29, 2018Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Afinion HbA1c Dx"
MAUDE reports
0
Brand "Afinion HbA1c Dx", since 2015
PubMed studies
0
Mentioning "Afinion HbA1c Dx"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Afinion HbA1c Dx on Afinion 2
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K182988 · Decided Nov 29, 2018 · 31 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
- Afinion HbA1c Dx510(k)
K180296 · Decided May 7, 2018 · 94 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Glycated Hemoglobin/Glycated ProteinNational determinationOn the books190.21Updated Oct 1, 2026
- Glycated Hemoglobin/Glycated Protein (Addition of ICD-9-CM 271.3, Intestinal disaccharidase deficiencies and disaccharide malabsorption)Coding analysisReview closedCAG-00336NUpdated Sep 14, 2026
- Glycated Hemoglobin/Glycated Protein (Addition of CPT Code 83037, Hemoglobin; glycosylated [A1c] by device cleared by FDA for home use)Coding analysisReview closedCAG-00373NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Afinion HbA1c Dx", any status and sponsor, newest update first.
No registered device study names "Afinion HbA1c Dx".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Afinion HbA1c Dx", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PDJ
218 reports: 216 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Abbott Diagnostics Technologies AS
Z-2192-2020 · Started Mar 23, 2020
Reason given: The analyzer system may have an electrostatic discharge and sparking of the power supply provided with the analyzers resulting in the power supply becoming non-functional.
Cause as FDA categorized it: Device Design · Device type: Hemoglobin A1c Test System (PDJ)
Published research
The most relevant PubMed records for "Afinion HbA1c Dx"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PDJ.
- Tosoh Automated Glycohemoglobin Analyzer HLC-723GR01Tosoh Bioscience, Inc. · 510(k) 2025
- ADVIA Chemistry Enzymatic Hemoglobin Ale (Alc_E) AssaySiemens Healthcare Diagnostics, Inc. · 510(k) 2021
- Hemoglobin A1c Assay, Hemoglobin A1c Calibrators, Hemoglobin A1c ControlsAbbott Laboratories · 510(k) 2015
- H100Plus Hemoglobin Testing SystemShenzhen Lifotronic Technology Co., Ltd. · 510(k) 2026
- Medconn 8K Glycated Hemoglobin Test SystemShanghai Medconn Medical Technology Co., Ltd. · 510(k) 2026
- Medconn Glycated Hemoglobin Test systemShanghai Medconn Medical Technology Co., Ltd. · 510(k) 2025
- Hipro Glycosylated Hemoglobin (HbA1c) Test SystemShijiazhuang Hipro Biotechnology Co., Ltd. · 510(k) 2024
- Tina-quant Hemoglobin A1cDx Gen.3Roche Diagnostics Operations (Rdo) · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.